These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 20622720

  • 1. Livedoid vasculopathy in a woman with multiple myeloma.
    Verma R, Hadid TH, Dhamija R, Moad JC, Loehrke ME.
    South Med J; 2010 Aug; 103(8):848-9. PubMed ID: 20622720
    [No Abstract] [Full Text] [Related]

  • 2. Prevention of recurrent ulceration of livedoid vasculopathy with long-term apixaban monotherapy.
    Osada SI, Ishikawa N, Hasunuma N, Manabe M.
    J Dermatol; 2019 Apr; 46(4):e142-e143. PubMed ID: 30156315
    [No Abstract] [Full Text] [Related]

  • 3. What caused this painful skin erosion? Livedoid vasculopathy.
    Monroe JR.
    JAAPA; 2012 May; 25(5):20. PubMed ID: 22712143
    [No Abstract] [Full Text] [Related]

  • 4. Dabigatran in the management of livedoid vasculopathy.
    Sawada T, Suehiro M.
    Clin Exp Dermatol; 2017 Mar; 42(2):237-239. PubMed ID: 28052437
    [No Abstract] [Full Text] [Related]

  • 5. Livedoid vasculopathy with underlying subcutaneous necrotizing venulitis in an asymptomatic hepatitis B virus carrier: is livedoid vasculopathy a true nonvasculitic disorder?
    Ishibashi M, Miyamoto J, Nagasaka T, Chen KR.
    Am J Dermatopathol; 2009 May; 31(3):293-6. PubMed ID: 19384073
    [Abstract] [Full Text] [Related]

  • 6. Livedoid vasculopathy presenting with leg ulcers.
    Kumar A, Sharma A, Agarwal A.
    Rheumatology (Oxford); 2019 Nov 01; 58(11):2076. PubMed ID: 31220328
    [No Abstract] [Full Text] [Related]

  • 7. Case of livedoid vasculopathy with peripheral neuropathy successfully treated with low-dose warfarin.
    Osada S, Kimura Y, Kawana S.
    J Dermatol; 2010 Jan 01; 37(1):98-101. PubMed ID: 20175830
    [Abstract] [Full Text] [Related]

  • 8. Expanding the spectrum of livedoid vasculopathy: peculiar neuromuscular manifestations.
    Allenbach Y, Tourte M, Stenzel W, Goebel HH, Maisonobe T, Frances C, Barete S, Benveniste O.
    Neuropathol Appl Neurobiol; 2015 Oct 01; 41(6):849-52. PubMed ID: 25871345
    [No Abstract] [Full Text] [Related]

  • 9. [Livedo reticularis due to cold gelation of the blood by gamma-plasmacytoma].
    LANGHOF H, BRAUN G, MATZKOWSKI H.
    Arch Klin Exp Dermatol; 1957 Oct 01; 205(4):343-50. PubMed ID: 13522017
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Livedoid vasculopathy associated with peripheral neuropathy: a report of two cases.
    Tubone MQ, Escobar GF, Peruzzo J, Schestatsky P, Maldonado G.
    An Bras Dermatol; 2013 Oct 01; 88(6 Suppl 1):227-9. PubMed ID: 24346927
    [Abstract] [Full Text] [Related]

  • 12. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) and prothrombin G20210A heterozygosity: response to t-PA therapy.
    Antunes J, Filipe P, André M, Fraga A, Miltenyi G, Marques Gomes M.
    Acta Derm Venereol; 2010 Oct 01; 90(1):91-2. PubMed ID: 20107738
    [No Abstract] [Full Text] [Related]

  • 13. Sensory ganglionopathy with livedoid vasculopathy controlled by immunotherapy.
    Alix JJ, Hadjivassiliou M, Ali R, Slater D, Messenger AG, Rao DG.
    Muscle Nerve; 2015 Feb 01; 51(2):296-301. PubMed ID: 25196820
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic effect of lipoprostaglandin E1 on livedoid vasculitis associated with essential cryoglobulinaemia.
    Kawakami T, Kawasaki K, Mizoguchi M, Soma Y.
    Br J Dermatol; 2007 Nov 01; 157(5):1051-3. PubMed ID: 17725674
    [No Abstract] [Full Text] [Related]

  • 15. [Livedoid vasculopathy. Pathogenesis, diagnosis and treatment of cutaneous infarction].
    Goerge T.
    Hautarzt; 2011 Aug 01; 62(8):627-34; quiz 635. PubMed ID: 21786003
    [Abstract] [Full Text] [Related]

  • 16. Livedoid vasculopathy associated with sickle cell trait: significant improvement on aspirin treatment.
    El Khoury J, Taher A, Kurban M, Kibbi AG, Abbas O.
    Int Wound J; 2012 Jun 01; 9(3):344-7. PubMed ID: 22044499
    [Abstract] [Full Text] [Related]

  • 17. Livedoid vasculopathy and recurrent thrombosis in a patient with lupus: seronegative antiphospholipid syndrome?
    Sopeña B, Pérez-Rodríguez MT, Rivera A, Ortiz-Rey JA, Lamas J, Freire-Dapena MC.
    Lupus; 2010 Oct 01; 19(11):1340-3. PubMed ID: 20659971
    [Abstract] [Full Text] [Related]

  • 18. Increased serum CXCR2 ligand levels in livedo vasculopathy with winter ulcerations: Possible contribution of neutrophil recruitment to lesional skin.
    Yang L, Murota H, Shindo S, Yang F, Serada S, Fujimoto M, Naka T, Katayama I.
    J Dermatol Sci; 2016 Apr 01; 82(1):57-9. PubMed ID: 26827264
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of livedoid vasculopathy with alprostadil (PGE-1): case report and review of published literature.
    Mofarrah R, Aberer W, Aberer E.
    J Eur Acad Dermatol Venereol; 2013 Feb 01; 27(2):e252-4. PubMed ID: 22364635
    [No Abstract] [Full Text] [Related]

  • 20. Livedoid vasculopathy: review of pathogenesis, clinical presentation, diagnostic workup, and treatment.
    Haunson GT, Judy DW, Prall NC, Miller RA.
    Cutis; 2012 Dec 01; 90(6):302-6. PubMed ID: 23409480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.